Your browser doesn't support javascript.
loading
Vedolizumab for Treating Moderately to Severely Active Crohn's Disease After Prior Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Rafia, Rachid; Scope, Alison; Harnan, Sue; Stevens, John W; Stevenson, Matt; Lobo, Alan.
Afiliação
  • Rafia R; School of Health and Related Research (ScHARR), University of Sheffield, Regent Court, 30 Regent Street, Sheffield, S1 4DA, UK. r.rafia@sheffield.ac.uk.
  • Scope A; School of Health and Related Research (ScHARR), University of Sheffield, Regent Court, 30 Regent Street, Sheffield, S1 4DA, UK.
  • Harnan S; School of Health and Related Research (ScHARR), University of Sheffield, Regent Court, 30 Regent Street, Sheffield, S1 4DA, UK.
  • Stevens JW; School of Health and Related Research (ScHARR), University of Sheffield, Regent Court, 30 Regent Street, Sheffield, S1 4DA, UK.
  • Stevenson M; School of Health and Related Research (ScHARR), University of Sheffield, Regent Court, 30 Regent Street, Sheffield, S1 4DA, UK.
  • Lobo A; Gastroenterology Service, Sheffield Teaching Hospitals NHS Foundation Trust, University of Sheffield, Sheffield, UK.
Pharmacoeconomics ; 34(12): 1241-1253, 2016 12.
Article em En | MEDLINE | ID: mdl-27480631
Assuntos
Buscar no Google
Imprimir
XML
PubMed Links

Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Doença de Crohn / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials / Health_economic_evaluation / Health_technology_assessment / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Buscar no Google
Imprimir
XML
PubMed Links

Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Doença de Crohn / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials / Health_economic_evaluation / Health_technology_assessment / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article